Literature DB >> 34135715

Bezafibrate Add-On Therapy Improves Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis: A Japanese Nationwide Cohort Study.

.   

Abstract

Entities:  

Year:  2021        PMID： 34135715      PMCID： PMC8191833     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  1 in total

Review 1.  Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.

Authors:  Chang Wang; Ying Shi; Xiaomei Wang; Heming Ma; Quan Liu; Yanhang Gao; Junqi Niu
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.